| # | Drug | Count |
|---|---|---|
| 0 | BIMATOPROST | 56 |
| 1 | SUNITINIB MALATE | 30 |
| 2 | LATANOPROST | 21 |
| 3 | PAZOPANIB HYDROCHLORIDE | 18 |
| 4 | ACETAMINOPHEN | 10 |
| 5 | ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | 10 |
| 6 | ERGOCALCIFEROL | 10 |
| 7 | OMEPRAZOLE MAGNESIUM | 10 |
| 8 | CYCLOSPORINE | 9 |
| 9 | ASPIRIN | 8 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | EYE CREAM | 1 | 0.0909 |
| 1 | TEBENTAFUSP | 4 | 0.0066 |
| 2 | PEXIDARTINIB HYDROCHLORIDE | 4 | 0.0056 |
| 3 | NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONE | 1 | 0.0049 |
| 4 | POLYETHYLENE GLYCOL AND PROPYLENE GLYCOL | 3 | 0.0041 |
| 5 | POLYETHYLENE GLYCOL 400 AND PROPYLENE GLYCOL | 4 | 0.0035 |
| 6 | TOVORAFENIB | 1 | 0.0031 |
| 7 | BIMATOPROST | 56 | 0.0019 |
| 8 | LATANOPROST OPHTHALMIC SOLUTION 0.005% | 1 | 0.0016 |
| 9 | L-LYSINE | 1 | 0.0014 |
| # | Drug class | Count |
|---|---|---|
| 0 | Prostaglandin Analog [EPC] | 78 |
| 1 | Expectorant [EPC] | 12 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 12 |
| 3 | Benzodiazepine [EPC] | 10 |
| 4 | Proton Pump Inhibitor [EPC] | 10 |
| 5 | Provitamin D2 Compound [EPC] | 10 |
| 6 | Vitamin C [EPC] | 10 |
| 7 | Calcineurin Inhibitor Immunosuppressant [EPC] | 9 |
| 8 | Kinase Inhibitor [EPC] | 9 |
| 9 | Dihydropyridine Calcium Channel Blocker [EPC] | 8 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Bispecific gp100 Peptide-HLA-directed CD3 T Cell Engager [EPC] | 4 | 0.0066 |
| 1 | Semifluorinated Alkane [EPC] | 2 | 0.0009 |
| 2 | Prostaglandin Analog [EPC] | 78 | 0.0008 |
| 3 | Non-Standardized Fungal Allergenic Extract [EPC] | 1 | 0.0005 |
| 4 | Provitamin D2 Compound [EPC] | 10 | 0.0003 |
| 5 | Antiseptic [EPC] | 1 | 0.0002 |
| 6 | Ergot Derivative [EPC] | 1 | 0.0002 |
| 7 | Calcitonin Gene-related Peptide Receptor Antagonist [EPC] | 1 | 0.0001 |
| 8 | Cannabinoid [EPC] | 1 | 0.0001 |
| 9 | Lymphocyte Function-Associated Antigen-1 Antagonist [EPC] | 2 | 0.0001 |